Search Results - "Resche-Rigon M"

Prevalence, characteristics and prognostic significance of anemia in daily practice.

Authors: Terrier, B. Resche-Rigon, M. Andres, E. et al.

Source: QJM: An International Journal of Medicine. Apr2012, Vol. 105 Issue 4, p345-354. 10p.

Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.

Authors: Saadoun D Resche-Rigon M Thibault V et al.

Source: Arthritis & Rheumatism. Nov2006, Vol. 54 Issue 11, p3696-3706. 11p.

1077MO PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study.

Authors: Delyon, J. Resche-Rigon, M. Renaud, M. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS732-S732. 1p.

Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study.

Authors: Biard, L. Porcher, R. Resche‐Rigon, M.

Source: Statistics in Medicine. Jul2014, Vol. 33 Issue 17, p3047-3057. 11p.

L’origine géographique dans la maladie de Behçet influence le phénotype clinique et le pronostic.

Authors: Saadoun, D. Resche Rigon, M. Wechsler, B. et al.

Source: Revue de Médecine Interne. Jun2013, Vol. 34, pA75-A76. 2p.

Efficacité du tocilizumab au cours de la maladie de Takayasu : étude française multicentrique rétrospective de 46 patients.

Authors: Mekinian, A. Resche-Rigon, M. Comarmond, C. et al.

Source: Revue de Médecine Interne. Jun2018 Supplement 1, Vol. 39, pA65-A66. 1p.

Y a-t-il une valeur ajoutée de l’échographie de la veine cave inférieure pour le traitement des patients critiques en ventilation spontanée ?

Authors: Goguey, C. Resche-Rigon, M. Robert, F.-X. et al.

Source: Annales Francaises d'Anesthesie & de Reanimation. Sep2014 Supplement 2, Vol. 33, pA339-A340. 1p.

O.095 Antiviral therapy for HCV-associated cryoglobulinemia vasculitis: A long term follow-up

Authors: Cacoub, P. Resche-Rigon, M. Thibault, V. et al.

Source: Journal of Clinical Virology. Jul2006 Supplement 2, Vol. 36 Issue s2, pS27-S28. 0p.

Prognosis of neutropenic patients admitted to the intensive care unit.

Authors: Mokart, D. Darmon, M. Resche-Rigon, M. et al.

Source: Intensive Care Medicine. Feb2015, Vol. 41 Issue 2, p296-303. 8p.

Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.

Authors: Petit-Topin, I. Fay, M. Resche-Rigon, M. et al.

Source: Journal of Steroid Biochemistry & Molecular Biology. Oct2014:Part B, Vol. 144, p427-435. 9p.

Trends in death attributed to myocardial infarction, heart failure and pulmonary embolism in Europe and Canada over the last decade.

Authors: Laribi, S. Aouba, A. Resche-Rigon, M. et al.

Source: QJM: An International Journal of Medicine. Oct2014, Vol. 107 Issue 10, p813-820. 8p.

Immunosuppressants reduce venous thrombosis relapse in Behçet's disease.

Authors: Desbois, A. C. Wechsler, B. Resche-Rigon, M. et al.

Source: Arthritis & Rheumatism. Aug2012, Vol. 64 Issue 8, p2753-2760. 8p.

Oesophagogastrectomy and pancreatoduodenectomy for caustic injury.

Authors: Lefrancois, M. Gaujoux, S. Resche-Rigon, M. et al.

Source: British Journal of Surgery. Jul2011, Vol. 98 Issue 7, p983-990. 8p. 2 Color Photographs, 1 Diagram, 1 Chart.

Dose-finding design driven by efficacy in onco-hematology phase I/II trials.

Authors: Seegers, V. Chevret, S. Resche-Rigon, M.

Source: Statistics in Medicine. 6/15/2011, Vol. 30 Issue 13, p1574-1583. 10p.

Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction.

Authors: Lukaszewicz AC Grienay M Resche-Rigon M et al.

Source: Critical Care Medicine. Oct2009, Vol. 37 Issue 10, p2746-2752. 7p.

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Authors: Groheux, David Biard, L. Lehmann-Che, J. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2018, Vol. 45 Issue 8, p1279-1288. 10p. 6 Charts, 1 Graph.

Investigating covariate-by-centre interaction in survival data.

Authors: Biard, L. Labopin, M. Chevret, S. et al.

Source: Statistical Methods in Medical Research. Mar2018, Vol. 27 Issue 3, p920-932. 13p.

Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.

Authors: Colombier, M.‐A. Lafaurie, M. Fontbrune, F.S. et al.

Source: Transplant Infectious Disease. Aug2016, Vol. 18 Issue 4, p504-511. 8p.

Multiple imputation: a mature approach to dealing with missing data.

Authors: Chevret, S. Seaman, S. Resche-Rigon, M.

Source: Intensive Care Medicine. Feb2015, Vol. 41 Issue 2, p348-350. 3p.

The value of five blood markers in differentiating mycosis fungoides and Sézary syndrome: a validation cohort*.

Authors: Dobos, G. De Cevins, C. Ly Ka So, S. et al.

Source: British Journal of Dermatology. Aug2021, Vol. 185 Issue 2, p405-411. 7p.